Document Type : Original Article
Authors
1 Department of Health Information Technology, School of Paramedical, Ilam University of Medical Sciences, Ilam, Iran
2 Department of Health Information Technology, Abadan Faculty of Medical Sciences, Abadan, Iran
3 Department of Laboratory Sciences, Abadan Faculty of Medical Sciences, Abadan, Iran
4 Department of Health Information Technology and Management, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Abstract
INTRODUCTION: The 2019 coronavirus disease (COVID‑19) is a major global health concern. Joint
efforts for effective surveillance of COVID‑19 require immediate transmission of reliable data. In this
regard, a standardized and interoperable reporting framework is essential in a consistent and timely
manner. Thus, this research aimed at to determine data requirements towards interoperability.
MATERIALS AND METHODS: In this cross‑sectional and descriptive study, a combination of
literature study and expert consensus approach was used to design COVID‑19 Minimum Data
Set (MDS). A MDS checklist was extracted and validated. The definitive data elements of the MDS
were determined by applying the Delphi technique. Then, the existing messaging and data standard
templates (Health Level Seven‑Clinical Document Architecture [HL7‑CDA] and SNOMED‑CT) were
used to design the surveillance interoperable framework.
RESULTS: The proposed MDS was divided into administrative and clinical sections with three and
eight data classes and 29 and 40 data fields, respectively. Then, for each data field, structured data
values along with SNOMED‑CT codes were defined and structured according HL7‑CDA standard.
DISCUSSION AND CONCLUSION: The absence of effective and integrated system for COVID‑19
surveillance can delay critical public health measures, leading to increased disease prevalence and
mortality. The heterogeneity of reporting templates and lack of uniform data sets hamper the optimal
information exchange among multiple systems. Thus, developing a unified and interoperable reporting
framework is more effective to prompt reaction to the COVID‑19 outbreak.
Keywords
- Jung S‑m, Akhmetzhanov AR, Hayashi K, Linton NM, Yang Y,
Yuan B, et al. Real‑time estimation of the risk of death from novel
coronavirus (covid‑19) infection: Inference using exported cases.
J Clin Med 2020;9:523. - 2. Dong E, Du H, Gardner L. An interactive web‑based dashboard
to track COVID‑19 in real time. Lancet Infect Dis 2020;20:533‑4.
3. Wu C, Chen X, Cai Y, Zhou X, Xu S, Huang H, et al. Risk factors
associated with acute respiratory distress syndrome and death
in patients with coronavirus disease 2019 pneumonia in Wuhan,
China. JAMA Int Med; 2020 March13.
4. Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute
respiratory syndrome coronavirus 2 (SARS‑CoV‑2) and corona
virus disease‑2019 (COVID‑19): The epidemic and the challenges.
Int J Antimicrob Agents 2020; 3 (55).
5. Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, et al. Presumed
asymptomatic carrier transmission of COVID‑19 2020 Apr 14;
323(14):1406‑7.
6. Linton NM, Kobayashi T, Yang Y, Hayashi K, Akhmetzhanov AR,
Jung SM, et al. Epidemiological characteristics of novel
coronavirus infection: A statistical analysis of publicly available
case data. medRxiv; 2020.
7. Organization WH. Coronavirus Disease 2019 (COVID‑19):
Situation Report; 2020. p. 45.
8. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical
characteristics of coronavirus disease 2019 in China. N Engl J Med
2020;382:1708‑20.
9. Richards CL, Iademarco MF, Atkinson D, Pinner RW, Yoon P,
Mac Kenzie WR, et al. Advances in public health surveillance and
information dissemination at the centers for disease control and
prevention. Public Health Rep 2017;132:403‑10.
10. Dixon BE, Rahurkar S, HoY, Arno JN. Reliability of administrative
data to identify sexually transmitted infections for population
health: A systematic review. BMJ Health Care Inform 2019 Aug1;
26(1).
11. Streefkerk HR, Verkooijen RP, Bramer WM, Verbrugh HA.
Electronically assisted surveillance systems of healthcare‑associated
infections: A systematic review. Euro Surveill 2020 Jan16; 25(2).
12. Allam Z, Jones DS. On the coronavirus (COVID‑19) outbreak
and the smart City Network: Universal Data Sharing Standards
Coupled with Artificial Intelligence (AI) to Benefit Urban Health
Monitoring and Management. Healthcare (Basel) 2020 Feb22; 8(1).
13. Safdari R, Ghazi Saeedi M, Masoumi‑Asl H, Rezaei‑Hachesu P,
Mirnia K, Mohammadzadeh N, et al. National minimum data
set for antimicrobial resistance management: Toward global
surveillance system. Iran J Med Sci 2018;43:494‑505.
14. Garcia MC, Garrett NY, Singletary V, Brown S, Hennessy‑Burt T,
Haney G, et al. An assessment of information exchange practices,
challenges and opportunities to support US disease surveillance
in three states. J Public Health Manag Practice 2018;24:546.
15. Gansel X, Mary M, van Belkum A. Semantic data interoperability,
digital medicine, and e‑health in infectious disease management:
A review. Eur J Clin Microbiol Infect Dis 2019;38:1023‑34.
16. Pilot E, Roa R, Jena B, Kauhl B, Krafft T, Murthy G. Towards
sustainable public health surveillance in India: Using routinely
collected electronic emergency medical service data for early
warning of infectious diseases. Sustainability 2017;9:604.
17. Gazzarata R, Monteverde ME, Ruggiero C, Maggi N, Palmieri D,
Parruti G, et al. Healthcare associated infections: An interoperable
infrastructure for multidrug resistant organism surveillance. Int
J Environ Res Public Health 2020 Jan; 17(2):465.
18. Sheikhali SA, Abdallat M, Mabdalla S, Al Qaseer B, Khorma R,
Malik M, et al. Design and implementation of a national
public health surveillance system in Jordan. Int J Med Inform
2016;88:58‑61.
19. Cato KD, Cohen B, Larson E. Data elements and validation
methods used for electronic surveillance of health care‑associated
infections: A systematic review. Am J Infect Control 2015;43:600‑5.
20. Raeisi A, Tabrizi JS, Gouya MM. IR of Iran national mobilization
against COVID‑19 Epidemic. Arch Iran Med 2020;23:216‑9.
21. Mounesan L, Eybpoosh S, Haghdoost A, Moradi G, Mostafavi E.
Is reporting many cases of COVID‑19 in Iran due to strength or
weakness of Iran’s health system? Iran J Microbiol 2020;12:73‑6.
22. Moradzadeh R. The challenges and considerations of
community‑based preparedness at the onset of COVID‑19
outbreak in Iran, 2020. Epidemiol Infect 2020;148:e82.
23. Shanbehzadeh M, Ahmadi M. Identification of the necessary data
elements to report AIDS: A systematic review. Electron Physician
2017;9:5920‑31.
24. Kazemi‑Arpanahi H, Vasheghani‑Farahani A, Baradaran A,
Mohammadzadeh N, Ghazisaeedi M. Developing a minimum
data set (MDS) for cardiac electronic implantable devices
implantation. Acta Inform Med 2018;26:164‑8.
25. Kazemi‑Arpanahi H, Vasheghani‑Farahani A, Baradaran A,
Ghazisaeedi M, Mohammadzadeh N, Bostan H. Development of
a minimum data set for cardiac electrophysiology study ablation.
J Educ Health Promot 2019;8:101.
26. Baunsgaard CB, Chhabra H, Harvey L, Savic G, Sisto SA,
Qureshi F, et al. Reliability of the international spinal cord injury
musculoskeletal basic data set. Spinal cord 2016;54:1105‑13.
27. Davey CJ, Slade SV, Shickle D. A proposed minimum data set for
international primary care optometry: A modified Delphi study.
Ophthalmic Physiol Opt 2017;37:428‑39.
28. Revere D, Hills RH, Dixon BE, Gibson PJ, Grannis SJ. Notifiable
condition reporting practices: Implications for public health
agency participation in a health information exchange. BMC
Public Health 2017;17:247.
29. Wilkinson MD, Dumontier M, Aalbersberg IJ, Appleton G,
Axton M, Baak A, et al. The FAIR Guiding Principles for scientific
data management and stewardship. Sci Data 2016; 3.
30. Haywood KL, Griffin XL, Achten J, Costa ML. Developing a core
outcome set for hip fracture trials. Bone Joint J 2014;96‑B:1016‑23.
31. Lutomski JE, Baars MA, Schalk BW, Boter H, Buurman BM,
den Elzen WP, et al. The development of the older persons and
informal caregivers survey minimum dataset (TOPICS‑MDS):
A large‑scale data sharing initiative. PloS One 2013;8:e81673.
32. Riley WT, Glasgow RE, Etheredge L, Abernethy AP. Rapid,
responsive, relevant (R3) research: A call for a rapid learning
health research enterprise. Clin Translat Med 2013;2:10.
33. Reza G, Fatemeh H. Covid‑19 and Iran: Swimming with hands
tied! Swiss Med Weekly 2020 Apr 7; 150(1516).
34. Zandifar A, Badrfam R. Fighting COVID‑19 in Iran; Economic
challenges ahead. Arch Iran Med 2020;23:284.
35. Raoofi A, Takian A, Akbari Sari A, Olyaeemanesh A, Haghighi H,
Aarabi M. COVID‑19 Pandemic and Comparative Health Policy
Learning in Iran. Arch Iran Med 2020;23:220‑34.
36. Gong M, Liu L, Sun X, Yang Y, Wang S, Zhu H. Cloud‑based
system for effective surveillance and control of COVID‑19:
Useful experiences from Hubei, China. J Med Internet Res 2020;
22:e18948.
37. Desjardins MR, Hohl A, Delmelle EM. Rapid surveillance of
COVID‑19 in the United States using a prospective space‑time
scan statistic: Detecting and evaluating emerging clusters. Appl
Geography 2020;118.
38. Foddai A, Lindberg A, Lubroth J, Ellis‑Iversen J. Surveillance to
improve evidence for community control decisions during the
COVID‑19 pandemic– Opening the animal epidemic toolbox for
Public Health. One Health 2020; 9.
39. Liu D, Wang X, Pan F, Xu Y, Yang P, Rao K. Web‑based
infectious disease reporting using XML forms. Int J Med Inform
2008;77:630‑40.
40. Kokkinakis I, Selby K, Favrat B, Genton B, Cornuz J.Covid‑19
diagnosis: Clinical recommendations and performance of
nasopharyngeal swab‑PCR. Rev Med Suisse 2020;16:699‑701.
)